Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations

URN to cite this document:: urn:nbn:de:bvb:355-epub-404431
DOI to cite this document:: 10.5283/epub.40443

Berger, Raffaela S.

; Ellmann, Lisa ; Reinders, Joerg ; Kreutz, Marina ; Stempfl, Thomas ; Oefner, Peter J. ; Dettmer, Katja

Preview

License: Creative Commons Attribution 4.0
PDF
(1MB)

Date of publication of this fulltext: 03 Jul 2019 15:14

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

D-2-Hydroxyglutarate (D-2-HG) is regarded as an oncometabolite. It is found at elevated levels in certain malignancies such as acute myeloid leukaemia and glioma. It is produced by a mutated isocitrate dehydrogenase IDH1/2, a low-affinity/high-capacity enzyme. Its degradation, in contrast, is catalysed by the high-affinity/low-capacity enzyme D-2-hydroxyglutarate dehydrogenase (D2HDH). So far, it ...